Rutin-whey protein isolate composite emulsion for promoting bone health and application of rutin-whey protein isolate composite emulsion

By combining rutin with whey isolate, it is prepared into an emulsion form, and the problems of low stability and packaging efficiency of the covalent complex of protein and rutin in the prior art are solved, and free radical removal and supplementation are achieved. High-quality protein, promoting bone health effects.

CN118924877APending Publication Date: 2024-11-12NAT INST FOR NUTRITION & HEALTH CHINESE CENT FOR DISEASE CONTROL & PREVENTION +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410995323.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-24
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

It is difficult to develop a safe, stable and efficient protein and rutin covalent complex for promoting bone health, and its in vitro research effects are difficult to convert into clinical effects.

Method used

By combining rutin with whey protein isolate and preparing it into a specific emulsion form, the physical and chemical stability of rutin is improved, and its encapsulation efficiency is enhanced to form a rutin-whey protein isolate complex emulsion.

Benefits of technology

Effectively remove free radicals, supplement high-quality proteins, promote bone health, improve the stability and packaging efficiency of rutin, and significantly improve the effectiveness of bone health.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924877A_ABST
    Figure CN118924877A_ABST
Patent Text Reader

Abstract

The invention relates to a rutin-whey protein isolate composite emulsion for promoting bone health and application thereof, and the rutin-whey protein isolate composite emulsion for promoting bone health is prepared by a method comprising the following steps: mixing a rutin solution, a whey protein isolate solution and an oil phase; the rutin-whey protein isolate composite emulsion is obtained. According to the rutin-whey protein isolate composite emulsion for promoting bone health, the physical and chemical stability of rutin is effectively improved, and the packaging efficiency of rutin is improved, so that skeletal muscle health can be maintained and promoted from two aspects of scavenging free radicals and supplementing high-quality protein. And the product is easily available in preparation raw materials, convenient in process and easy for large-scale production, and can be used as a dietary nutritional ingredient preparation for development of related products such as food.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of health food, and in particular to a rutin-whey protein isolate composite emulsion promoting bone health and application thereof. Background Art

[0002] Sarcopenia is an age-related geriatric syndrome characterized by decreased muscle mass, decreased muscle strength and / or decreased physical function. Although the onset of sarcopenia is insidious, it can cause serious body dysfunction, increase the risk of falls, disability and death in the elderly, and seriously damage the quality of life and health of the elderly. In addition to improving unhealthy lifestyles and increasing exercise, nutritional supplementation is also an effective way to prevent and treat sarcopenia in the elderly. Adequate protein intake is a necessary condition to ensure muscle mass and muscle quality. Studies have found that protein intake is positively correlated with the maintenance of muscle mass. Protein supplementation can effectively alleviate the aging-induced decrease in protein synthesis. Ensuring 25-30g of protein intake per meal can effectively stimulate the synthesis of myosin, and essential amino acids have an important influence on myosin synthesis. Among them, the three branched-chain amino acids leucine, isoleucine and valine are important components for maintaining the health of skeletal muscle in the elderly.

[0003] In addition, aging is accompanied by the accumulation of reactive oxygen species (ROS) in the body, which attacks normal cell structures and leads to irreversible cell function loss or apoptosis. Studies have shown that the higher the level of antioxidant components in the blood, the lower the risk of muscle strength loss. Some food-derived antioxidant components, such as resveratrol, salidroside, and calycosin, have been shown to have the effect of scavenging free radicals and improving the level of skeletal muscle oxidative stress.

[0004] Rutin is a flavonoid dietary polyphenol with multiple health effects such as antioxidant, anti-inflammatory, anti-cancer, anti-diabetic, and neuroprotective. When rutin was administered to mice fed a high-fat diet, mitochondrial biosynthesis and AMPK activity in skeletal muscle were significantly increased, showing a weight control effect. However, rutin has low water solubility, poor stability, and limited membrane permeability, and its physiological effects observed in in vitro studies are not always effectively converted into clinical effects. Whey protein isolate is an important protein ingredient and functional dietary nutrient preparation in the food industry, containing a variety of proteins such as α-lactalbumin, β-lactoglobulin, immunoglobulin, and lactoferrin. Studies have found that whey protein isolate is rich in essential amino acids, among which the content of three branched-chain amino acids, leucine, isoleucine, and valine, is as high as 20%, and plays an important role in protein metabolism, blood sugar stability, and lipid metabolism. The synergistic effect of rutin and whey protein isolate can effectively scavenge free radicals and supplement high-quality protein to promote bone health.

[0005] The covalent complex formed by protein and rutin will not only limit the release of rutin, but also reduce the solubility of protein. The encapsulation efficiency of hydrophobic nutritional drugs can be effectively improved by using emulsions. Therefore, how to develop a safe, stable and efficient product for promoting bone health has become an urgent problem to be solved. Summary of the invention

[0006] In view of the deficiencies of the prior art, the object of the present invention is to provide a rutin-whey protein isolate composite emulsion and its application for promoting bone health.

[0007] In order to achieve the purpose of the invention, the present invention adopts the following technical solutions:

[0008] In a first aspect, the present invention provides a rutin-whey protein isolate composite emulsion that promotes bone health, wherein the rutin-whey protein isolate composite emulsion that promotes bone health is prepared by a method comprising the following steps:

[0009] The rutin solution, the whey protein isolate solution and the oil phase are mixed to obtain the rutin-whey protein isolate composite emulsion.

[0010] In the present invention, by combining rutin and whey protein isolate and preparing them into a specific emulsion form, a composite emulsion product that can effectively promote bone health is obtained. Among them, rutin, as a flavonoid dietary polyphenol, has multiple health effects such as anti-oxidation, anti-inflammatory, anti-cancer, anti-diabetes, and neuroprotection. And whey protein isolate plays an important role in promoting protein metabolism, blood sugar stability and lipid metabolism. Rutin and whey protein isolate can effectively remove free radicals and supplement high-quality protein to promote bone health by synergistic action. At the same time, it is prepared into a specific emulsion dosage form, which improves the physical and chemical stability of rutin and improves its encapsulation efficiency, further enhancing the effect of promoting bone health.

[0011] Preferably, the solvent of the rutin solution comprises anhydrous ethanol.

[0012] Preferably, the solvent of the whey protein isolate solution comprises water.

[0013] Preferably, the concentration of rutin in the rutin-whey protein isolate composite emulsion is 8-15 mg / mL, for example, it can be 8 mg / mL, 8.5 mg / mL, 9 mg / mL, 9.5 mg / mL, 10 mg / mL, 10.5 mg / mL, 11 mg / mL, 11.5 mg / mL, 12 mg / mL, 12.5 mg / mL, 13 mg / mL, 13.5 mg / mL, 14 mg / mL, 14.5 mg / mL, 15 mg / mL, etc. Other specific point values ​​within this numerical range can be selected, which will not be repeated here one by one.

[0014] Preferably, the concentration of whey protein isolate in the rutin-whey protein isolate composite emulsion is 5-10wt%, for example, it can be 5wt%, 5.2wt%, 5.5wt%, 5.8wt%, 6wt%, 6.2wt%, 6.5wt%, 6.8wt%, 7wt%, 7.2wt%, 7.5wt%, 7.8wt%, 8wt%, 8.2wt%, 8.5wt%, 8.8wt%, 9wt%, 9.2wt%, 9.5wt%, 9.8wt%, 10wt% etc., other specific point values ​​within this numerical range can be selected, and will not be repeated here one by one.

[0015] Preferably, the oil phase comprises edible tea oil.

[0016] The present invention further improves the stability and encapsulation rate of rutin in the prepared rutin-whey protein isolate composite emulsion by selecting a specific oil phase component, and has better effects of scavenging free radicals and supplementing high-quality protein.

[0017] Preferably, the ratio of rutin, whey protein isolate and oil phase is 1 g: (6-10) g: (30-80) mL;

[0018] The above-mentioned "6-10" can be, for example, 6, 6.2, 6.5, 6.8, 7, 7.2, 7.5, 7.8, 8, 8.2, 8.5, 8.8, 9, 9.2, 9.5, 9.8, 10, etc. Other specific point values ​​within the numerical range can be selected, and they will not be described one by one here;

[0019] The above-mentioned "30-80" can be, for example, 30, 32, 35, 38, 40, 42, 45, 48, 50, 52, 55, 58, 60, 62, 65, 68, 70, 72, 75, 78, 80, etc. Other specific point values ​​within this numerical range can be selected, and they will not be elaborated here one by one.

[0020] The present invention adopts a specific ratio between rutin, whey protein isolate and oil phase to prepare an emulsion product with higher rutin stability and better rutin encapsulation effect, thereby further improving the effect of the emulsion product in promoting bone health.

[0021] Preferably, the mixing method includes homogenization.

[0022] Preferably, the homogenization speed is 10000-15000rpm, for example, it can be 10000rpm, 10500rpm, 11000rpm, 11500rpm, 12000rpm, 12500rpm, 13000rpm, 13500rpm, 14000rpm, 14500rpm, 15000rpm, etc. Other specific point values ​​within the numerical range can be selected, which will not be described here one by one.

[0023] Preferably, the homogenization time is 1-5min, for example, it can be 1min, 1.2min, 1.5min, 1.8min, 2min, 2.2min, 2.5min, 2.8min, 3min, 3.2min, 3.5min, 3.8min, 4min, 4.2min, 4.5min, 4.8min, 5min, etc. Other specific point values ​​within this numerical range can be selected, which will not be elaborated here.

[0024] In a second aspect, the present invention provides a use of the rutin-whey protein isolate composite emulsion according to the first aspect in the preparation of a drug for preventing, improving or treating skeletal muscle attenuation.

[0025] In a third aspect, a use of the rutin-whey protein isolate composite emulsion according to the first aspect in the preparation of a drug for protecting and / or improving skeletal muscle structure.

[0026] Preferably, the drug further comprises pharmaceutically acceptable excipients.

[0027] Preferably, the auxiliary materials include any one or a combination of at least two of fillers, pH regulators, antioxidants, binders, wetting agents, disintegrants, emulsifiers, cosolvents, solubilizers, osmotic pressure regulators, colorants, antibacterial agents or buffers.

[0028] Compared with the prior art, the present invention has the following beneficial effects:

[0029] The present invention creatively develops a rutin-whey protein isolate composite emulsion that promotes bone health. Rutin and whey protein isolate work synergistically to effectively remove free radicals and supplement high-quality protein to promote bone health. At the same time, it is prepared into a specific emulsion dosage form, which improves the physical and chemical stability of rutin and its encapsulation efficiency, and maintains and promotes skeletal muscle health from the two aspects of removing free radicals and supplementing high-quality protein. In addition, the product preparation raw materials are easily available, the process is convenient, and it is easy to mass produce, and it can be used as a dietary nutrient preparation for the development of related products such as food. BRIEF DESCRIPTION OF THE DRAWINGS

[0030] Figure 11 is a graph showing the storage stability of the rutin-whey protein isolate composite emulsion prepared in Example 1-3;

[0031] Figure 2-1 is the average particle size and potential diagram of the rutin-whey protein isolate composite emulsion prepared in Examples 1-9;

[0032] Figure 2-2 is a particle size distribution diagram of the rutin-whey protein isolate composite emulsion prepared in Example 1-3;

[0033] Figure 2-3 is a particle size distribution diagram of the rutin-whey protein isolate composite emulsion prepared in Example 4-6;

[0034] Figure 2-4 is a particle size distribution diagram of the rutin-whey protein isolate composite emulsion prepared in Examples 7-9;

[0035] Figure 3 is a statistical result diagram of the embedding efficiency and loading rate of rutin by the rutin-whey protein isolate composite emulsion prepared in Examples 1-9;

[0036] Figure 4 is a graph showing the tolerance of the rutin-whey protein isolate composite emulsion prepared in Example 1 in simulated gastric juice and intestinal juice;

[0037] Figure 5 is a graph showing the thermal stability of the rutin-whey protein isolate composite emulsion prepared in Example 1;

[0038] Figure 6 1 is a diagram showing the analysis results of the effect of the rutin-whey protein isolate composite emulsion prepared in Example 1 on the movement of zebrafish;

[0039] Figure 7 This is a test and analysis result diagram of the effect of the rutin-whey protein isolate composite emulsion prepared in Example 1 on the forelimb grip strength of mice. DETAILED DESCRIPTION

[0040] The technical solution of the present invention is further described below by specific implementation methods. It should be understood by those skilled in the art that the embodiments are only to help understand the present invention and should not be regarded as specific limitations of the present invention.

[0041] The rutin involved in the following examples is a product of model number Rutin (98%) purchased from Nanjing Jingzhu Biotechnology Co., Ltd.;

[0042] Whey protein isolate (98% by mass) was purchased from DAVISCO, USA;

[0043] Edible tea oil was purchased from Qiyunshan Food Co., Ltd. (Jiangxi, China);

[0044] The malondialdehyde content detection kit was purchased from Nanjing Jiancheng Bioengineering Institute with model number A003-1.

[0045] In the result graphs of the following examples, lowercase letters indicate significant differences (p<0.05); uppercase letters indicate extremely significant differences (p<0.01); when the letters in each group are the same, the difference is not significant; when the letters are completely different, the difference is significant or extremely significant.

[0046] Example 1

[0047] This embodiment provides a composite emulsion, and the preparation method thereof is as follows:

[0048] 1.6 g of whey protein isolate was dissolved in 9 mL of deionized water, and heated in a water bath at 50° C. for 45 min to fully dissolve the whey protein isolate in the aqueous solution to obtain a whey protein isolate solution, 0.2 g of rutin was fully dissolved in 1 mL of anhydrous ethanol, and then mixed evenly with the whey protein isolate solution to obtain a whey protein isolate rutin aqueous solution. 10 mL of edible tea oil was used as the oil phase, the oil phase was mixed with the whey protein isolate rutin aqueous solution, and then homogenized for 2 min at 13000 rpm by a homogenizer to obtain the composite emulsion.

[0049] Example 2

[0050] This embodiment provides a composite emulsion, and the preparation method thereof is as follows:

[0051] 3 g of whey protein isolate was dissolved in 18 mL of deionized water, and heated in a water bath at 50° C. for 50 min to fully dissolve the whey protein isolate in the aqueous solution to obtain a whey protein isolate solution, 0.5 g of rutin was fully dissolved in 2 mL of anhydrous ethanol, and then mixed evenly with the whey protein isolate solution to obtain a whey protein isolate rutin aqueous solution. 20 mL of edible tea oil was used as the oil phase, the oil phase was mixed with the whey protein isolate rutin aqueous solution, and then homogenized by a homogenizer at 10000 rpm for 5 min to obtain the composite emulsion.

[0052] Example 3

[0053] This embodiment provides a composite emulsion, and the preparation method thereof is as follows:

[0054] 5 g of whey protein isolate was dissolved in 22 mL of deionized water, and heated for 60 min in a water bath at 50° C. to fully dissolve the whey protein isolate in the aqueous solution to obtain a whey protein isolate solution, 0.7 g of rutin was fully dissolved in 3 mL of anhydrous ethanol, and then mixed evenly with the whey protein isolate solution to obtain a whey protein isolate rutin aqueous solution. 25 mL of edible tea oil was used as the oil phase, the oil phase was mixed with the whey protein isolate rutin aqueous solution, and then homogenized for 1.5 min at 14000 rpm by a homogenizer to obtain the composite emulsion.

[0055] Example 4

[0056] This embodiment provides a composite emulsion, and the preparation method thereof is different from that of Embodiment 1 only in that the amount of whey protein isolate used is 0.6 g.

[0057] Example 5

[0058] This embodiment provides a composite emulsion, and the preparation method thereof is different from that of Embodiment 1 only in that the amount of whey protein isolate used is 3 g.

[0059] Example 6

[0060] This embodiment provides a composite emulsion, and the preparation method thereof is different from that of Embodiment 1 only in that the amount of edible tea oil used is 5 mL.

[0061] Example 7

[0062] This embodiment provides a composite emulsion, and the preparation method thereof is different from that of embodiment 1 only in that soybean oil is used as the oil phase.

[0063] Example 8

[0064] This embodiment provides a composite emulsion, and the preparation method thereof is different from that of embodiment 1 only in that corn oil is used as the oil phase.

[0065] Example 9

[0066] This embodiment provides a composite emulsion, and the preparation method thereof is different from that of embodiment 1 only in that rapeseed oil is used as the oil phase.

[0067] Test Example 1

[0068] This test example tests the stability of the composite emulsions prepared in Examples 1-3 immediately after preparation and stored in a sealed container at 25°C for 7 days. The results are as follows: Figure 1 shown.

[0069] As can be seen from the figure, the rutin-whey protein isolate composite emulsion prepared by the present invention has relatively high stability, and no emulsion separation or stratification occurs even after being sealed and left to stand at 25° C. for 7 days.

[0070] Test Example 2

[0071] This test example tests the particle size and Zeta potential of the composite emulsions prepared in Examples 1-9. The composite emulsion solution is diluted to 1 mg / mL and the pH value is adjusted to 7 for measurement. All measurements are performed at 25°C. Each value represents the average and standard deviation (SD) of three repeated tests. The average particle size and potential results are shown in Figure 2-1 The particle size distribution diagram is shown in Figure 2-2 (Examples 1-3), Figure 2-3 (Examples 4-6) and Figure 2-4 (Examples 7-9) are shown.

[0072] As can be seen from the figure, the droplet size of the composite emulsion prepared in Example 1 is above 10 μm, and the average particle size is 1219 ± 256.36 nm. The Zeta potential is -19.47 ± 1.01 mV. And the particle size distribution presents a unimodal distribution, indicating that the particle size distribution in the composite emulsion system is uniform. It shows that the rutin-whey protein isolate composite emulsion product prepared by the present invention through the specific ratio between rutin, whey protein isolate and oil phase, and the selection of specific oil phase components has good emulsion properties.

[0073] (2) By comparing Example 1 with Examples 4-6, it can be seen that when the ratio of rutin, whey protein isolate and oil phase used is not within a specific range, the emulsion particle size increases significantly, the absolute value of the Zata potential decreases, and the particle size distribution has a multi-peak phenomenon. It can be seen that the present invention, through the specific ratio between rutin, whey protein isolate and oil phase, the prepared emulsion product has higher stability and emulsion characteristics.

[0074] (3) By comparing Example 1 with Examples 7-9, it can be seen that when soybean oil, corn oil, and rapeseed oil are used for preparation, compared with edible tea oil, the prepared rutin-whey protein isolate composite emulsion has no obvious difference in Zata potential, but the particle size is significantly increased, and the particle size distribution also shows multi-peak phenomenon to varying degrees. The results show that the emulsion product prepared by the specific selection of edible tea oil in the present invention has higher stability and emulsion properties.

[0075] Test Example 3

[0076] This test example tests the encapsulation efficiency of the composite emulsion prepared in Examples 1-9. Take 2 mL of the composite emulsion prepared in each group, centrifuge at 12000g for 30 minutes at 4°C, take 600 μL of the supernatant and mix it evenly with 400 μL of dimethyl sulfoxide (DMSO). Then measure the absorbance of each group of emulsion samples at 364 nm by ultraviolet spectrophotometer. Use the calibration curve established by the standard solution (rutin concentration in DMSO is 0-32 μg / mL) to determine the amount of rutin in the sample, and obtain the standard curve. The embedding efficiency (%) and loading capacity (%) of the composite emulsion are calculated according to the following formulas: embedding efficiency (%) = (total rutin content - free rutin content) / total rutin content × 100%; loading capacity (%) = (total rutin content - free rutin content) / emulsion mass × 100%. The results are as follows: Figure 3 shown.

[0077] Depend on Figure 3 It can be seen that:

[0078] (1) It can be seen from Examples 1 to 3 that the rutin-whey protein isolate composite emulsion provided by the present invention has an embedding efficiency of 71.16±0.13% for rutin, and a protein loading rate of 44.48±0.08 μg / mg. It can be seen that the present invention has prepared a rutin-whey protein isolate composite emulsion with high rutin embedding rate and loading rate.

[0079] (2) By comparing Example 1 with Examples 4-6, it can be seen that when the ratio of rutin, whey protein isolate and oil phase used is not within a specific range, the embedding effect of rutin and the loading rate of protein are both reduced compared with Example 1. It can be seen that the emulsion product prepared by the specific ratio of rutin, whey protein isolate and oil phase in the present invention has higher stability and encapsulation effect.

[0080] (3) By comparing Example 1 with Examples 7-9, it can be seen that the present invention further improves the stability and encapsulation efficiency of the prepared rutin-whey protein isolate composite emulsion by selecting a specific oil phase component, and has a better effect of scavenging free radicals and supplementing high-quality protein.

[0081] Test Example 4

[0082] This test example tests the tolerance of the composite emulsion prepared in Example 1 and the control group (10 mg / mL rutin solution) in simulated gastric juice and intestinal juice, and the steps are as follows:

[0083] (1) Preparation of simulated gastric fluid (SGF) (2000 U / mL pepsin, 0.15 mol / L NaCl, pH 2.0) and simulated intestinal fluid (SIF) (100 U / mL trypsin, 20 mg / mL bile salts, 10 mmol / L CaCl2, pH 7.4).

[0084] (2) Take 7.5 mL of the composite emulsion and rutin solution and mix them with 10 mL of SGF to simulate gastric digestion. Adjust the pH value of the system to 2, and shake continuously at 37°C and 100 rpm for 2 h to obtain a digestive solution; then simulate intestinal digestion of the gastric solution, mix the obtained digestive solution with 15 mL of SIF, adjust the pH to 7, and incubate in a shaker (37°C, 100 rpm / min) in the dark for 2 h. Then take 4 mL of the digestive solution, centrifuge at 25°C, 10000 g for 40 min, and collect the supernatant as the micellar phase. Take 1 mL of the supernatant and mix it evenly with 2 mL of methanol, centrifuge it at 8000 g at 25°C for 5 min, separate the upper micellar phase and the lower solution phase, mix the upper layer with 1 mL of methanol, centrifuge it at 8000 g at 25°C for 5 min, mix the lower solution phase with the above solution phase, and measure the absorbance at 364 nm. The retention rate and bioavailability of rutin were calculated using the following formula: Retention rate (%) = Mt / M0×100%; Bioavailability (%) = M micelle / M0×100%,M t is the residual content of rutin in the solution, M0 is the initial content of rutin in the sample solution, and M micelle is the content of rutin in the micellar phase. The results are as follows Figure 4 shown.

[0085] Depend on Figure 4 It can be seen that due to the good stability of rutin in an acidic environment, after 2 hours of gastric digestion, the loss of rutin in the control group and the Example 1 group was less than 30%. The release and dissolution of fat-soluble nutrients mainly occur in the digestion stage of the small intestine, which depends on a variety of exogenous factors such as molecular properties, food matrix, processing process and interface composition. After 2 hours of simulated intestinal digestion, the retention rate of rutin in the Example 1 group was 51%, while the retention rate of rutin in the control group that was not encapsulated was only 27%; the heated whey protein loaded rutin emulsion showed good rutin bioaccessibility (47.84±9.43%) after simulated gastrointestinal digestion, and the bioaccessibility was increased by about 3 times. It can be seen that the rutin-whey protein isolate composite emulsion prepared in Example 1 has a good rutin retention rate compared with the rutin solution that was not encapsulated in the control group, which can effectively avoid the premature release of rutin in the intestinal fluid for degradation.

[0086] Test Example 5

[0087] This test example tests the thermal stability of the composite emulsion prepared in Example 1. The results are as follows Figure 5 As shown, the test steps are as follows:

[0088] (1) Oil peroxide value (PV): 5 mL of the composite emulsion prepared in Example 1 stored at 4°C and 25°C for 35 days was placed in a 37°C incubator, and the oxidation products of oil in the sample were measured on the 7th, 14th, 21st, 28th and 35th days, respectively. The test method is as follows: 0.2 mL of the composite emulsion was mixed with 9.8 mL of chloroform-methanol (7:3 v / v) in a disposable glass tube, vortexed for 4 seconds, 0.05 mL of 30% ammonium thiocyanate solution and 0.05 mL of 0.132 mol / L ferrous chloride (dissolved in 10 mol / L HCl) solution were added, vortexed for 4 seconds, incubated at 25°C for 5 minutes, and the absorbance was measured at 500 nm using an ultraviolet spectrophotometer. A standard curve was drawn with 0-0.6 mol / L ferric chloride, and PV was expressed as the ferric chloride equivalent of peroxide in each milliliter of oil.

[0089] (2) Determination of secondary oxidation products of oils and fats: The malondialdehyde (MDA) content detection kit was used for determination. The content of malondialdehyde, a secondary oxidation product of oils and fats, was also determined on the 7th, 14th, 21st, 28th and 35th days.

[0090] Depend on Figure 5 It can be seen that the rutin-whey protein isolate composite emulsion prepared in Example 1 can significantly improve its storage stability, slow down the degradation rate of the sample, and has higher thermal stability.

[0091] Test Example 6

[0092] This test example tests the effect of the composite emulsion prepared in Example 1 on preventing skeletal muscle attenuation.

[0093] Wild-type AB strain zebrafish 3 days after fertilization were randomly selected in a 6-well plate and divided into 6 groups, each with 30 tails, and grouped as: Example 1 group (intestinal injection, 0.01 μL of 25% emulsion stock solution / tail), rutin group (intestinal injection, 25 ng / tail), whey protein isolate group (intestinal injection, 200 ng / tail), positive control group (62.5 μg / mL water-soluble trimetazidine), model group and normal control group, 3 mL of water per well, except for the normal control group, the remaining groups were given water-soluble dexamethasone to establish a zebrafish sarcopenia model, treated at 28°C for 96 h (48h liquid change), each experimental group randomly selected 10 zebrafish and placed in a 96-well plate, 1 tail / well, 200 μL / well, and the number of zebrafish movements and exercise time were measured using a behavior analyzer, and the statistical analysis of the above indicators was used to improve the mobility of the samples. The results are as follows Figure 6 The statistical results were expressed as mean ± SE. SPSS 26.0 software was used for statistical analysis, and p < 0.05 indicated that the difference was statistically significant.

[0094] Depend on Figure 6 The results show that the number of zebrafish movements in the model group is significantly lower than that in the normal group, while dexamethasone, rutin and whey protein isolate intervention did not significantly improve the number of zebrafish movements and exercise time; and after treatment with the rutin-whey protein isolate composite emulsion prepared in Example 1, the number of zebrafish movements and exercise time were significantly improved, up to 3 times that of the model group, and the exercise time can reach 2.66s, which is 4.9 times the exercise time of zebrafish in the model group. It can be seen that the rutin-whey protein isolate composite emulsion provided by the present invention can effectively enhance skeletal motor ability, prevent skeletal muscle attenuation, and improve skeletal muscle function.

[0095] Test Example 7

[0096] This test example tests the effect of the composite emulsion prepared in Example 1 on improving skeletal muscle function.

[0097] Select 8-week-old SPF male C57BL / 6J mice and randomly divide them into 5 groups, wherein the blank group is subjected to oral administration of sodium carboxymethylcellulose (CMC-Na) solution and injection of normal saline; the model group is subjected to oral administration of CMC-Na solution and injection of D-galactose to induce the generation of skeletal muscle attenuation symptoms; the rutin group is subjected to oral administration of rutin and CMC-Na solution and injection of D-galactose, the whey protein isolate group is subjected to oral administration of whey protein isolate emulsion and injection of D-galactose; the embodiment 1 group is subjected to oral administration of rutin-whey protein isolate emulsion and injection of D-galactose. The oral administration volume and injection volume are both 10mL / kg according to the weight of mice, the sample concentration of the rutin group is 10mg / mL, the whey protein isolate content in the whey protein isolate group is 8%, and the dosage of rutin and whey protein isolate is consistent with the content of the two in the rutin-whey protein isolate composite emulsion of the embodiment 1 group. Gavage and injection were performed once a day for 11 weeks. In the 9th and 10th weeks, the mice were suspended by their tails to lift their hind limbs off the ground. In the 11th week of the experiment, the forelimb grip strength test was performed. The forelimbs of the mice were naturally placed on the claw net of the grip strength tester, and a force parallel to the claw net was uniformly applied to the tail until the forelimbs of the mice fell off the claw net. The grip strength displayed by the instrument was recorded. The test and result analysis are as follows: Figure 7 shown.

[0098] Depend on Figure 7 The results show that compared with the blank group mice, the forelimb grip strength of the model group mice was significantly reduced, and no significant improvement was observed under the action of rutin and whey protein isolate alone. However, under the action of rutin-whey protein isolate composite emulsion, the forelimb grip strength of mice in the Example 1 group was significantly improved compared with the model group, indicating that the emulsion has the effect of improving skeletal muscle strength.

[0099] In summary, in the present invention, by combining rutin and whey protein isolate, and preparing them into a specific emulsion form, a composite emulsion product that can effectively promote bone health is obtained. Among them, rutin, as a flavonoid dietary polyphenol, has multiple health effects such as anti-oxidation, anti-inflammatory, anti-cancer, anti-diabetes, and neuroprotection. And whey protein isolate has an important promoting effect in protein metabolism, blood sugar stability and lipid metabolism. Rutin and whey protein isolate can effectively remove free radicals and supplement high-quality protein to promote bone health through synergistic action. At the same time, it is prepared into a specific emulsion dosage form, which improves the physical and chemical stability of rutin and improves its encapsulation efficiency, further enhancing the effect of promoting bone health.

[0100] The applicant declares that the present invention illustrates the technical solution of the present invention through the above-mentioned embodiments, but the present invention is not limited to the above-mentioned embodiments, that is, it does not mean that the present invention must rely on the above-mentioned embodiments to be implemented. Those skilled in the art should understand that any improvement of the present invention, equivalent replacement of various raw materials of the product of the present invention, addition of auxiliary components, selection of specific methods, etc., all fall within the protection scope and disclosure scope of the present invention.

[0101] The preferred embodiments of the present invention are described in detail above. However, the present invention is not limited to the specific details in the above embodiments. Within the technical concept of the present invention, a variety of simple modifications can be made to the technical solution of the present invention, and these simple modifications all belong to the protection scope of the present invention.

[0102] It should also be noted that the various specific technical features described in the above specific embodiments can be combined in any suitable manner without contradiction. In order to avoid unnecessary repetition, the present invention will not further describe various possible combinations.

Claims

1. A rutin-whey protein isolate composite emulsion for promoting bone health, characterized in that: The rutin-whey protein isolate composite emulsion for promoting bone health is prepared by a method comprising the following steps: The rutin solution, the whey protein isolate solution and the oil phase are mixed to obtain the rutin-whey protein isolate composite emulsion.

2. The rutin-whey protein isolate composite emulsion according to claim 1, characterized in that The solvent of the rutin solution includes anhydrous ethanol; Preferably, the solvent of the whey protein isolate solution comprises water.

3. The rutin-whey protein isolate composite emulsion according to claim 1 or 2, characterized in that The concentration of rutin in the rutin-whey protein isolate composite emulsion is 8-15 mg / mL.

4. The rutin-whey protein isolate composite emulsion according to claim 1 or 2, characterized in that The concentration of whey protein isolate in the rutin-whey protein isolate composite emulsion is 5-10wt%.

5. The rutin-whey protein isolate composite emulsion according to claim 1, characterized in that The oil phase includes edible tea oil.

6. The rutin-whey protein isolate composite emulsion according to any one of claims 1 to 5, characterized in that The ratio of the rutin, whey protein isolate and oil phase is 1 g: (6-10) g: (30-80) mL.

7. The rutin-whey protein isolate composite emulsion according to claim 1, characterized in that The mixing method includes homogenization; Preferably, the homogenizing speed is 10000-15000 rpm; Preferably, the homogenization time is 1-5 min.

8. Use of the rutin-whey protein isolate composite emulsion according to any one of claims 1 to 7 in the preparation of a drug for preventing, improving or treating skeletal muscle attenuation.

9. Use of the rutin-whey protein isolate composite emulsion according to any one of claims 1 to 7 in the preparation of a drug for protecting and / or improving skeletal muscle structure.

10. The use according to claim 8 or 9, characterized in that: The drug also includes pharmaceutically acceptable excipients; Preferably, the auxiliary materials include any one or a combination of at least two of fillers, pH regulators, antioxidants, binders, wetting agents, disintegrants, emulsifiers, cosolvents, solubilizers, osmotic pressure regulators, colorants, antibacterial agents or buffers.